Novo Nordisk agonist shows strong trial results as MASH cases rise among US adults For the first time, a GLP-1 therapy has been cleared to treat metabolic dysfunction-associated steatohepatitis (MASH), after the US Food and Drug Administration (FDA) granted accelerated approval to Novo Nordisks weight-loss drug Wegovy
Fuselier T, Mota de Sa P, Qadir MMF, Xu B, Allard C, Meyers MM, et al
But, if youre rightly concerned about the side effects of GLP-1 injections and the short-lived results, you can still improve your fertility, promote insulin sensitivity, and more with natural GLP-1 boosters like berberine and Inositol Complete 40:1
Example: You currently inject on Wednesdays
GLP-1 and GIP agonists in diabetes and obesity and the rise of dyspepsia
My Honest Take Look, Ive been doing this for a while, and GLP-1 medications are some of the most impressive treatments Ive seen for diabetes and weight management